Table 3 DFPP treatment and TG clearance during the first 48 h after diagnosis in patients according to DTD time tertiles.
All patients (n = 89) | T1: ≤ 12 h (n = 30) | T2:13–22 h (n = 30) | T3: ≥ 23 h (n = 29) | P value | |
|---|---|---|---|---|---|
DFPP treatment variables | |||||
Frequency of DFPP > 1, n (%) | 24 (27) | 11 (36.7) | 9 (30) | 4 (13.8) | 0.127 |
TG clearance rate, median (IQR), % | 73.63 (61.12–83.37) | 69.14 (43.3–83.3) | 75.45 (64.35–83.22) | 74.86 (65.12–84.38) | 0.276 |
Volume of plasma processed, median (IQR), L | 5 (3–5) | 4.3 (3–5) | 5 (3–5) | 5 (3–5) | 0.524 |
Treatment duration, median (IQR), min | 200 (147.5–250) | 180 (140–245) | 218 (160–280) | 200 (164–235) | 0.328 |
Dynamics of TG levels | |||||
TG0, median (IQR), mmol/L | 58.3 (39.69–80.05) | 63.58 (35.84–80.83) | 57.41 (44.44–76.75) | 54.26 (40.04–81.61) | 0.756 |
TG0 > 56.5 mmol, n (%) | 46 (51.7) | 16 (53.3) | 16 (53.3) | 14 (48.3) | 0.905 |
TG24h, median (IQR), mmol/L | 8.99(4.67–19.35) | 7.22 (3.04–14.77) | 5.84 (3.14–9.78) | 17.95 (16.58–27.64) | < 0.001 |
TG24h < 5.65 mmol/L, n (%) | 29 (32.6) | 15 (50) | 13 (43.3) | 1 (3.4) | < 0.001 |
TG48h, median (IQR), mmol/L | 4.44 (3.2–6.03) | 3.91 (3.19–5.41) | 4.27 (3.08–6.26) | 5 (3.64–7.31) | 0.178 |
TG48h < 5.65 mmol/L, n (%) | 67 (75.3) | 24 (80) | 23 (76.7) | 20 (69) | 0.603 |
24 h-TG clearance rate, median (IQR), % | 83.25 (69.53–91.45) | 86.15 (80–91.51) | 89.61 (83.01–94.44) | 52.54 (42.38–73.66) | < 0.001 |
48 h-TG clearance rate, median (IQR), % | 91.81 (87.91–94.02) | 91.95 (88.59–94.69) | 91.91 (87.96–94.21) | 91.4 (86.46–92.81) | 0.358 |